After a slow recovery in 2024, biotech companies looking to go public in 2025 may face more obstacles. While only

TCG Labs Soleil, a company that creates focused biotechnology startups and prepares them for partnerships, announced on Thursday that it

The European Medicines Agency (EMA) has recommended against approving Sarepta’s gene therapy, Elevidys, for Duchenne muscular dystrophy (DMD) after a

In the world of drug development, business deals are just as important as scientific discoveries. Many of today’s top-selling medicines,

Proximie has teamed up with HistoSonics to bring the Edison Histotripsy System to more hospitals and surgical centers across the

Drug prices, especially those set when new medications first hit the market, are climbing higher and higher, according to the

Seaport Therapeutics has started its phase 2b BUOY-1 trial for GlyphAllo, a new oral medication for major depressive disorder (MDD),

The biotech world is going through a tough time right now. So far this year, big companies buying smaller ones